Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-28 4:30 pm Unchanged | 2025-08-28 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 4.900% | 0 (Unchanged) | Filing History |
| 2025-08-25 4:12 pm Purchase | 2025-08-19 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Millennium Management LLC | 4,160,515 5.900% | 398,471 (+10.59%) | Filing History |
| 2025-08-20 5:18 pm Sale | 2025-08-18 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 5,985,327 8.600% | -8,444,663 (-58.52%) | Filing History |
| 2025-08-13 4:00 pm Purchase | 2025-08-11 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Millennium Management LLC | 3,762,044 5.300% | 3,762,044 (New Position) | Filing History |
| 2025-06-09 10:47 am Unchanged | 2025-05-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Jennison Associates LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-06-06 1:29 pm Sale | 2025-05-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | PRUDENTIAL FINANCIAL INC PRU | 2,630 0.000% | -7,416,132 (-99.96%) | Filing History |
| 2025-06-04 4:30 pm Sale | 2025-04-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Jennison Associates LLC | 0 0.000% | -6,993,422 (Position Closed) | Filing History |
| 2025-05-13 4:22 pm Purchase | 2025-05-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 14,429,990 19.900% | 1,641,280 (+12.83%) | Filing History |
| 2025-04-24 2:30 pm Purchase | 2025-03-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | BlackRock Inc. BLK | 3,226,286 4.600% | 103,716 (+3.32%) | Filing History |
| 2024-11-12 11:46 am Unchanged | 2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT | BlackRock Inc. BLK | 3,122,570 5.200% | 0 (Unchanged) | Filing History |
| 2024-11-05 4:12 pm Purchase | 2024-10-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | PRUDENTIAL FINANCIAL INC PRU | 7,418,762 11.000% | 1,137,033 (+18.10%) | Filing History |
| 2024-11-05 3:32 pm Purchase | 2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT | PRUDENTIAL FINANCIAL INC PRU | 6,281,729 9.300% | 6,281,729 (New Position) | Filing History |
| 2024-11-04 11:20 am Purchase | 2024-10-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Jennison Associates LLC | 6,993,422 10.400% | 6,993,422 (New Position) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT | BlackRock Inc. BLK | 3,122,570 5.200% | 3,122,570 (New Position) | Filing History |
| 2024-08-22 4:05 pm Purchase | 2024-08-20 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 12,788,710 18.000% | 2,618,922 (+25.75%) | Filing History |
| 2024-06-06 1:59 pm Purchase | 2024-03-07 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 10,169,788 17.400% | 44,000 (+0.43%) | Filing History |
| 2024-04-10 06:10 am Sale | 2024-04-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Takeda Pharmaceutical Company Limited | 2,790,480 4.800% | -362,737 (-11.50%) | Filing History |
| 2024-04-01 06:15 am Sale | 2024-03-28 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Takeda Pharmaceutical Company Limited | 3,153,217 5.400% | -602,366 (-16.04%) | Filing History |
| 2024-02-12 4:36 pm Purchase | 2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 6.100% | 561,702 (+19.14%) | Filing History |
| 2024-02-09 11:45 am Purchase | 2024-02-07 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Invesco Ltd. IVZ | 3,167,653 5.500% | 960,004 (+43.49%) | Filing History |